Safirstein Metcalf LLP announces that a class action has been filed on behalf of those who purchased securities of Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) between May 15, 2017 and June 5, 2018, both dates inclusive (the “Class Period”). If you…
Safirstein Metcalf LLP, announces that a class action lawsuit has been filed in the United States District Court Central District of California, on behalf of persons and entities that acquired Live Nation Entertainment, Inc. (“Live Nation” or the “Company”) (NYSE:LYV)…
Safirstein Metcalf LLP, announces that a class action lawsuit has been filed in the United States District Court Western District of Washington on behalf of persons and entities that acquired the common stock (“stock” or “shares”) of Funko, Inc. (NASDAQ:FNKO)…
Safirstein Metcalf LLP announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of persons or entities who purchased or otherwise acquired securities of TrueCar, Inc. (“TrueCar”)…
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP announces that a class action has been filed in the United States District Court, for the District of Illinois, Eastern Division, on behalf of a class consisting of investors…
Safirstein Metcalf LLP announces that a class action has been filed on behalf of those who purchased or otherwise acquired A10 Networks, Inc. (NYSE:ATEN) (“A10” or the “Company”) securities between February 9, 2016 and January 30, 2018, both dates inclusive…
Safirstein Metcalf LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all persons or entities that purchased Solid Biosciences Inc. (“Solid Biosciences” or the “Company”)…
Safirstein Metcalf LLP, announces that a class action lawsuit was filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Cancer Genetics, Inc. (NASDAQ:CGIX) (“Cancer Genetics”…